rs1042796

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001958.5(EEF1A2):​c.1326G>A​(p.Glu442Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.015 in 1,477,194 control chromosomes in the GnomAD database, including 1,651 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 474 hom., cov: 33)
Exomes 𝑓: 0.012 ( 1177 hom. )

Consequence

EEF1A2
NM_001958.5 synonymous

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.00

Publications

0 publications found
Variant links:
Genes affected
EEF1A2 (HGNC:3192): (eukaryotic translation elongation factor 1 alpha 2) This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer. [provided by RefSeq, Mar 2014]
EEF1A2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 33
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 20-63488364-C-T is Benign according to our data. Variant chr20-63488364-C-T is described in ClinVar as Benign. ClinVar VariationId is 380904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.151 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EEF1A2NM_001958.5 linkc.1326G>A p.Glu442Glu synonymous_variant Exon 8 of 8 ENST00000217182.6 NP_001949.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EEF1A2ENST00000217182.6 linkc.1326G>A p.Glu442Glu synonymous_variant Exon 8 of 8 1 NM_001958.5 ENSP00000217182.3

Frequencies

GnomAD3 genomes
AF:
0.0446
AC:
6771
AN:
151692
Hom.:
471
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.137
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0163
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000390
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.0336
GnomAD2 exomes
AF:
0.0288
AC:
2761
AN:
95750
AF XY:
0.0367
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.00445
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000865
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000742
Gnomad OTH exome
AF:
0.00859
GnomAD4 exome
AF:
0.0116
AC:
15402
AN:
1325394
Hom.:
1177
Cov.:
33
AF XY:
0.0149
AC XY:
9758
AN XY:
653674
show subpopulations
African (AFR)
AF:
0.137
AC:
3655
AN:
26722
American (AMR)
AF:
0.00750
AC:
201
AN:
26792
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23200
East Asian (EAS)
AF:
0.000142
AC:
4
AN:
28164
South Asian (SAS)
AF:
0.139
AC:
10097
AN:
72700
European-Finnish (FIN)
AF:
0.000147
AC:
6
AN:
40760
Middle Eastern (MID)
AF:
0.0125
AC:
65
AN:
5206
European-Non Finnish (NFE)
AF:
0.000297
AC:
311
AN:
1047422
Other (OTH)
AF:
0.0195
AC:
1063
AN:
54428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
577
1154
1731
2308
2885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0448
AC:
6805
AN:
151800
Hom.:
474
Cov.:
33
AF XY:
0.0462
AC XY:
3431
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.137
AC:
5687
AN:
41398
American (AMR)
AF:
0.0162
AC:
247
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000392
AC:
2
AN:
5108
South Asian (SAS)
AF:
0.160
AC:
769
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10536
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
67910
Other (OTH)
AF:
0.0332
AC:
70
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
292
583
875
1166
1458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0107
Hom.:
34
Bravo
AF:
0.0456
Asia WGS
AF:
0.0840
AC:
286
AN:
3422

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 21, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Developmental and epileptic encephalopathy, 33 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Mar 18, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
14
DANN
Uncertain
0.98
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042796; hg19: chr20-62119717; API